Medical Devices
Wearable Tremor Therapy Market

Wearable Tremor Therapy Market

Wearable Tremor Therapy Market - Global Industry Analysis 2015 - 2019 and Opportunity Assessment; 2020 - 2030

ID: PMRREP31881

Upcoming

Author : Abhijeet Surwase

Market Overview

Essential tremor is a disorder associated with the nervous system also referred to as a neurological disorder. Main symptom of essential tremor is involuntary and rhythmic shaking of body parts. Most commonly affected body part is hands, and trembling is seen while doing simple tasks like eating or drinking something or tying shoelaces.

Essential tremor is generally not a dangerous disease, but it can worsens with time. It can be even severe in some people. Essential tremor is usually confused with Parkinson's disease. Essential tremor occur a person uses his hands while Tremors from Parkinson's disease occur in resting position of hands.

Genetic mutation and age are the two main risk factors for essential tremors. Its occurrence is more common in people above the age of 40 years. If a parent has essential tremor condition it is likely to get transferred in children in 50% of the cases. Tremor control devices that can be worn on arms and wrists provide the invasive treatment characteristic for the condition.

The emerging interest in non- pharmacological approaches for conditions like essential tremors will tend to grow the wearable tremor therapy market. Wearable tremor therapy devices offer a joint multidisciplinary platform having engineering, physiology, robotics, physiotherapy, and clinical evaluation for meeting non-pharmacological intrusions for essential tremor. These tremors have more occurrence of 4% prevalence in old people (above 65 years).

ET has an incidence rate of 616 in 100000 population. Increasing geriatric population, increasing prevalence of essential tremor and non-responsive pharmacological treatments are definite factors that will drive the Wearable tremor therapy market. The usually recommended treatments like propranolol often proves to be in effective and develops drug tolerance.

As many patients poorly respond to such medications there is a growing attractiveness towards Wearable tremor therapy options and contribute in driving the market. However lack of sufficient evidence regarding the efficacy of Wearable tremor therapy devices can majorly restrain the market growth.

The validation studies done on Wearable tremor therapy devices should consider same scientific research methodology like used for clinical trials. Only then there can be an adequate level of evidence of the data. Poor understanding of such technologies amongst people who are less literate especially in the lower economic regions can restrict the Wearable tremor therapy market growth.